Incidence of pediatric inflammatory bowel disease in Saudi Arabia: a multicenter national study

Mohammad I El Mouzan1, Omar Saadah, Khalid Al-Saleem

  • 11Department of Pediatrics, Division of Gastroenterology, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia; 2Department of Pediatrics, Division of Gastroenterology, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia; 3Department of Pediatrics, Division of Gastroenterology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; 4Department of Pediatrics, Division of Gastroenterology, Dhahran Health Center, Saudi Aramco Medical Services Organization, Dhahran, Saudi Arabia; 5Department of Pediatrics, Division of Gastroenterology, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Saudi Arabia; 6Department of Pediatrics, Division of Gastroenterology, King Fahad Specialist Hospital, Dammam, Saudi Arabia; 7Department of Pediatrics, Division of Gastroenterology, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia; 8Department of Gastroenterology, Al-Mofarreh Polyclinic, Riyadh, Saudi Arabia; 9Division of Gastroenterology, King Fahad Medical City, Children's Hospital, Riyadh, Saudi Arabia; 10Department of Medicine, Division of Gastroenterology, King Fahd Hospital of the University, University of Dammam, Al Khobar, Saudi Arabia; 11Department of Pediatrics, Division of Gastroenterology, Al-Noor Specialist Hospital, Makkah, Saudi Arabia; 12Division of Gastroenterology, Maternity and Children's Hospital, Madinah, Saudi Arabia; 13Department of Pediatrics, Division of Gastroenterology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia; 14Division of Gastroenterology, Maternity and Children's Hospital, Dammam, Saudi Arabia; 15Division of Gastroenterology, Makkah Maternity and Children's Hospital, Makkah, Saudi Arabia; and 16Department of Pediatrics, Division of Gastroenterology, Prince Sultan Military Medical City. Riyadh, Saudi Arabia.

Insights

The incidence of pediatric inflammatory bowel disease (IBD) in Saudi Arabia is rising, particularly in older children, though it remains lower than in Western countries. Further research is needed to understand risk factors.

Area of Science:

  • Pediatric Gastroenterology
  • Epidemiology
  • Inflammatory Bowel Disease (IBD) Research

Background:

  • Pediatric inflammatory bowel disease (IBD) recognition is growing in developing nations.
  • Data on pediatric IBD incidence and trends in Saudi Arabia were previously unavailable.

Purpose of the Study:

  • To determine the incidence and temporal trends of pediatric IBD in Saudi Arabia.
  • To compare ulcerative colitis and Crohn's disease incidence across different age groups.

Main Methods:

  • Retrospective analysis of 340 children diagnosed with IBD between 2003 and 2012 in Saudi Arabia.
  • Data collection included demographics, diagnosis dates, and clinical, laboratory, imaging, endoscopic, and histopathological findings.
  • Statistical analysis used descriptive statistics, chi-square tests, and Poisson distribution for incidence and trend analysis.

Main Results:

  • The mean incidence rates per 100,000 were 0.2 for ulcerative colitis, 0.27 for Crohn's disease, and 0.47 for overall IBD.
  • A significant increasing trend in pediatric IBD incidence was observed over time, except in the 0-4 year age group.
  • Incidence rates were lower than those reported in Western literature.

Conclusions:

  • Pediatric IBD incidence in Saudi Arabia shows a significant upward trend, despite being lower than Western rates.
  • A decreasing incidence trend was noted in the youngest age group (0-4 years).
  • Prospective studies are recommended to identify specific risk factors for pediatric IBD in various age demographics.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
33
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
42
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K